Litigation Details for HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES UT, INC. (D.N.J. 2015)
✉ Email this page to a colleague
HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES UT, INC. (D.N.J. 2015)
Docket | ⤷ Try a Trial | Date Filed | 2015-10-27 |
Court | District Court, D. New Jersey | Date Terminated | 2017-05-23 |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | Referred To | ||
Patents | 8,217,078; 8,252,838; 8,563,613; 8,871,809; 9,066,913; 9,101,591; 9,132,110 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES UT, INC.
Details for HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES UT, INC. (D.N.J. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-10-10 | 101 | assignee of U.S. Patent Nos. 8,217,078 (“the ’078 patent”); 9,132,110 (“the ’110 patent”); 8,618,164 (…Drug Application No. 204623 and of U.S. Patent Nos. 8,217,078; 8,252,838; 8,546,450; 8,563,613; 9,066,913… (“the ’164 patent”); 9,168,304 (“the ’304 patent”); 9,168,305 (“the ’305 patent”); 8,546,450 (“the ’… ’450 patent”); 9,101,591 (“the ’591 patent”); 8,563,613 (“the ’613 patent”); 9,220,784 (“the ’784 patent… patent”); 8,871,809 (“the ’809 patent”); 8,252,838 (“the ’838 patent”); and 9,066,913 (“the ’913 patent | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |